OncoTherapy Science, Inc. announced a private placement of 540,000 36th stock acquisition rights at a price of ¥7 per warrant for the gross proceeds of ¥3,780,000 on April 5, 2024. The transaction will include participation from new investor, Long Corridor Asset Management Limited, Long Corridor Alpha Opportunities Master Fund. The warrants will be convertible into common shares at an exercise of ¥19 per share.

The transaction has been approved by the shareholders of the company and is expected to close on April 22, 2024.